Sanofi (SNY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 50.03 |
| Open | 50.31 |
| Bid | 49.80 x 1200 |
| Ask | 51.32 x 1800 |
| Day's range | 50.17 - 51.01 |
| 52-week range | 46.93 - 58.10 |
| Volume | |
| Avg. volume | 2,525,869 |
| Market cap | 127.388B |
| Beta (5Y monthly) | 0.36 |
| PE ratio (TTM) | 18.28 |
| EPS (TTM) | 2.79 |
| Earnings date | N/A |
| Forward dividend & yield | 1.75 (3.49%) |
| Ex-dividend date | 26 May 2022 |
| 1y target est | 70.75 |
- Zacks
Sanofi's (SNY) Studies on BTK Inhibitor Put on Hold by FDA
Sanofi (SNY) pauses enrollment in late-stage studies evaluating its BTK inhibitor in multiple sclerosis and myasthenia gravis after the FDA places a partial clinical hold on these studies.
- Zacks
The Zacks Analyst Blog Highlights Sanofi, Merck, Novartis, Pfizer and J&J
Sanofi, Merck, Novartis, Pfizer and J&J are part of Zacks top Analyst Blog.
- Zacks
Pharma Stock Roundup: FDA Panel Backs Updated COVID Jabs, EU Nod for SNY, MRK Drugs
An FDA panel recommends updating COVID-19 booster shots. EU approvals for Sanofi's (SNY) two new drugs and expanded use of Merck's (MRK) Keytruda and Novartis' (NVS) Cosentyx.
© 2022 Yahoo. All rights reserved.
